Enzymatic assessment

The reactant is referred to as a substrate. Alternatively it may be a nutrient for the growth of cells or its main function may require being transformed into some desirable chemical. The cells select reactants that will be combined and molecules that may be decomposed by using enzymes. These are produced only by living organisms, and commercial enzymes are produced by bacteria. Enzymes operate under mild conditions of temperature and pH. A database of the various types of enzymes and functions can be assessed from the following web site http //www.expasy.ch/enzyme/. This site also provides information about enzymatic reactions. 

The pH dependence of HIV-1 protease has been assessed by measuring the apparent inhibition constant for a synthetic substrate analog (b). The data are consistent with the catalytic involvement of ionizable groups with pK values of 3.3 and 5.3. Maximal enzymatic activity occurs in the pH range between these two values. On the basis of the accumulated kinetic and structural data on HIV-1 protease, these pK values have been ascribed to the... 

White L.O. Reeves D.S. (1983) Enzymatic assay of aminoglycoside antibiotics. In Antibiotics Assessment of Antimicrobial Activity and Resistance (eds A.D. Russell L.B. Quesnel), pp. 199-210. Society for Applied Bacteriology Technical Series No. 18. London Academic Press. 

Pectin degradation requires fee combined action of various enzymatic activities. However, evaluation of fee contribution of individual pectinases in Suit juice extraction and clarification is rather complicated. Most commercial pectinolytic enzyme preparations are produced by fermentation wife filamentous fungi, mostly strains belonging to fee genus Aspergillus,. plication studies with mixtures of isolat enzymes obtained by fermentation or by means of fractionation of commercial enzyme preparations can be used to assess the importance of fee various individual enzymes. Subsequently, molecular biology and fermentation technology can be used to enhance specific desirable enzymatic activities. 

Figure 5.3 A convenient scheme for performing an inhibitor titration in 96-well format. Four compounds (1-4) are assessed in duplicate at each of 11 inhibitor concentrations. The inhibitor concentrations follow a threefold serial dilution from a maximum concentration of 1000 (molarity units nM, LlM, etc.). The right most column of wells is reserved for control samples. In this illustration four of the wells of column 12 are used for zero inhibitior positive controls, and the other four are used to establish the assay background as negative controls. Negative controls could represent any sample for which one knows that the enzymatic reaction has be abrogated. For example, the negative control wells could contain all of the reaction mixture components except the enzyme. See Chapter 4 for other potential forms of negative controls.

The formation of 5-hydroxy-2 -deoxycytidine (22) and 5-hydroxy-2 -de-oxyuridine (23) that arise from dehydration of dCyd glycols 20 and related dUrd derivatives 21, respectively, was assessed by HPLC-electrochemical detection within calf thymus DNA upon exposure to photoexcited menadione and subsequent enzymatic hydrolysis [57]. The latter two oxidized nucleo-... 

In regard to the antineoplastic potentials of Rubiaceae, some evidence has already been presented that clearly demonstrates that anthraquinones inhibit the enzymatic activity of topoisomerase II. An example of antineoplastic anthraquinones that target topoisomerase II is mitoxantrone (Novatrone ), which is currently approved for clinical use in the United States (16). In the Pacific Rim, about 150 species of plants classified within the family Rubiaceae are medicinal, of which Prismatomeris albidiflora, Krtoxia valeriartoides, Damnacanthus indicus, and Morinda umbellata are known to produce anthraquinones. An interesting development from Rubiaceae would be to investigate its members for anthraquinones and assess them for topoisomerase inhibitors. The discovery of inhibitors of topoisomerase II of clinical antineoplastic value can be reasonably expected. 

D. indicus Gaertn. is known to abound with anthraquinones, but its pharmacological potential remains unexplored to date (20,21). Note that damnacanthal is a common component of the Damnacanthus species. Faltynek et al. made the interesting observation that damnacanthal inhibits the enzymatic activity of tyrosine kinase, which is involved in the propagation of metastases (22). An interesting development from this observation would be to assess the topoisomerase inhibitory activity of the Damnacan-thus species, an activity that could be associated with tyrosine kinase inhibition, hence enormous chemotherapeutic potentials. 

These rules can be used in conjunction with experimental inhibition studies to assess the plausibility of possible enzymatic mechanisms. 

Two recently published patent applications [44,45] extended previously described work by the same group [21]. Enzymatic data in the patent applications is reported in ranges (<1, 1-10, >10 iM, etc), making it difficult to thoroughly assess the compounds covered in the claims. Bissulfonamide 35 is a representative compound and is reported to inhibit both ACC1 and ACC2 with IC50 s < 5 iM. 

Measurement of exoenzymatic activities is potentially useful in detecting the effects of toxicants on heterotrophic biofilm communities. Sensitivity and direct relationship with organic matter use and, therefore, microbial growth make extracellular enzyme activities a relevant tool to assess the toxicity of specific compounds. Use of novel approaches that combine enzymatic and microscopic tools (e.g. ELF-phosphatase) may be extremely useful to detect anomalies at the sub-cellular scale. 

The enzymatic activity in soil is mainly of microbial origin, being derived from intracellular, cell-associated or free enzymes. Only enzymatic activity of ecto-enzymes and free enzymes is used for determination of the diversity of enzyme patterns in soil extracts. Enzymes are the direct mediators for biological catabolism of soil organic and mineral components. Thus, these catalysts provide a meaningful assessment of reaction rates for important soil processes. Enzyme activities can be measured as in situ substrate transformation rates or as potential rates if the focus is more qualitative. Enzyme activities are usually determined by a dye reaction followed by a spectrophotometric measurement. 

Enzyme-linked immunosorbent assay (ELISA) is comparable to the immuno-radiometric assay except that an enzyme tag is attached to the antibody instead of a radioactive label. ELISAs have the advantage of nonradioactive materials and produce an end product that can be assessed with a spectrophotometer. The molecule of interest is bound to the enzyme-labeled antibody, and the excess antibody is removed for immunoradiometric assays. After excess antibody has been removed or the second antibody containing the enzyme has been added (two-site assay), the substrate and cofactors necessary are added in order to visualize and record enzyme activity. The level of molecule of interest present is directly related to the level of enzymatic activity. The sensitivity of the ELISAs can be enhanced by increasing the incubation time for producing substrate. 

Many factors may confound the assessment of the D DI potential of early discovery compounds [93], Limited or no solubility data exist to understand the likelihood that the compound will precipitate out of an in vitro incubation. The compounds have generally not been analyzed from a spectroscopic perspective their characteristics may interfere with a fluorogenic DDI assay. Metabolism data are typically not available. The binding of a compound to plasma proteins or microsomal incubation constituents is not well understood, which may lead to underprediction of its inhibitory potential. The compounds are typically delivered in DMSO, which may cause solvent-related inhibition of the enzymatic assay. Also, since little is known about in vivo concentrations or projected dose, framing the consequences of an early DDI in vitro experiment may be difficult. With these factors in mind, general experimental paradigms have been developed to help minimize their potential impact. 

---